These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32956191)

  • 1. Managing Dyspnea in Individuals With Idiopathic Pulmonary Fibrosis.
    Fenwick KE; Swan BA
    J Hosp Palliat Nurs; 2020 Dec; 22(6):447-455. PubMed ID: 32956191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic breathlessness in patients with idiopathic pulmonary fibrosis: a major challenge for caregivers.
    O'Donnell DE; Neder JA; Harle I; Moran-Mendoza O
    Expert Rev Respir Med; 2016 Dec; 10(12):1295-1303. PubMed ID: 27766905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buccal Hydromorphone Syrup for Managing Dyspnea in Idiopathic Pulmonary Fibrosis.
    Fong S; Richman-Eisenstat J; Kalluri M
    Am J Hosp Palliat Care; 2021 Aug; 38(8):1046-1052. PubMed ID: 33138638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity and quality of life improvements of patients with idiopathic pulmonary fibrosis completing a pulmonary rehabilitation program.
    Gaunaurd IA; Gómez-Marín OW; Ramos CF; Sol CM; Cohen MI; Cahalin LP; Cardenas DD; Jackson RM
    Respir Care; 2014 Dec; 59(12):1872-9. PubMed ID: 25185149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of non-pharmacological nursing interventions to improve the quality of life of patients with idiopathic pulmonary fibrosis: A systematic review.
    Igai Y
    Jpn J Nurs Sci; 2019 Jul; 16(3):241-252. PubMed ID: 30430734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease.
    Wuyts WA; Wijsenbeek M; Bondue B; Bouros D; Bresser P; Robalo Cordeiro C; Hilberg O; Magnusson J; Manali ED; Morais A; Papiris S; Shaker S; Veltkamp M; Bendstrup E
    Respiration; 2020; 99(1):73-82. PubMed ID: 31830755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis.
    Prior TS; Hilberg O; Shaker SB; Davidsen JR; Hoyer N; Birring SS; Bendstrup E
    BMC Pulm Med; 2019 Dec; 19(1):255. PubMed ID: 31856786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.
    Yount SE; Beaumont JL; Chen SY; Kaiser K; Wortman K; Van Brunt DL; Swigris J; Cella D
    Lung; 2016 Apr; 194(2):227-34. PubMed ID: 26861885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyspnea in idiopathic pulmonary fibrosis: a systematic review.
    Ryerson CJ; Donesky D; Pantilat SZ; Collard HR
    J Pain Symptom Manage; 2012 Apr; 43(4):771-82. PubMed ID: 22285287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
    Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.
    Glaspole IN; Chapman SA; Cooper WA; Ellis SJ; Goh NS; Hopkins PM; Macansh S; Mahar A; Moodley YP; Paul E; Reynolds PN; Walters EH; Zappala CJ; Corte TJ
    Respirology; 2017 Jul; 22(5):950-956. PubMed ID: 28166611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.
    Ryerson CJ; Camp PG; Eves ND; Schaeffer M; Syed N; Dhillon S; Jensen D; Maltais F; O'Donnell DE; Raghavan N; Roman M; Stickland MK; Assayag D; Bourbeau J; Dion G; Fell CD; Hambly N; Johannson KA; Kalluri M; Khalil N; Kolb M; Manganas H; Morán-Mendoza O; Provencher S; Ramesh W; Rolf JD; Wilcox PG; Guenette JA
    Ann Am Thorac Soc; 2016 Sep; 13(9):1640-7. PubMed ID: 27348402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking dyspnea up to supplemental oxygen prescription among patients with pulmonary fibrosis.
    Olson AL; Graney B; Baird S; Churney T; Fier K; Korn M; McCormick M; Sprunger D; Vierzba T; Wamboldt FS; Swigris JJ
    BMC Pulm Med; 2017 Nov; 17(1):152. PubMed ID: 29166901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis.
    Vainshelboim B; Oliveira J; Yehoshua L; Weiss I; Fox BD; Fruchter O; Kramer MR
    Respiration; 2014; 88(5):378-88. PubMed ID: 25341682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive and practical approach to the management of idiopathic pulmonary fibrosis.
    Moran-Mendoza O; Colman R; Kalluri M; Cabalteja C; Harle I
    Expert Rev Respir Med; 2019 Jul; 13(7):601-614. PubMed ID: 31177864
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of palliative care on quality of life, anxiety, and depression in idiopathic pulmonary fibrosis: a randomized controlled pilot study.
    Janssen K; Rosielle D; Wang Q; Kim HJ
    Respir Res; 2020 Jan; 21(1):2. PubMed ID: 31900187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of idiopathic pulmonary fibrosis on patients' emotional well being and quality of life: a literature review.
    Antoniou K; Kamekis A; Symvoulakis EK; Kokosi M; Swigris JJ
    Curr Opin Pulm Med; 2020 Sep; 26(5):457-463. PubMed ID: 32701673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise training in idiopathic pulmonary fibrosis.
    Vainshelboim B; Fox BD; Oliveira J; Kramer MR
    Expert Rev Respir Med; 2016; 10(1):69-77. PubMed ID: 26567878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia.
    Nishiyama O; Miyajima H; Fukai Y; Yamazaki R; Satoh R; Yamagata T; Sano H; Iwanaga T; Higashimoto Y; Nakajima H; Kume H; Tohda Y
    Respir Med; 2013 Aug; 107(8):1241-6. PubMed ID: 23806287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners.
    Lindell KO; Olshansky E; Song MK; Zullo TG; Gibson KF; Kaminski N; Hoffman LA
    Heart Lung; 2010; 39(4):304-13. PubMed ID: 20561836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.